Multifunctional Synthetic Protein Nanoparticles via Reactive Electrojetting
Daniel F Quevedo1,2, Nahal Habibi1,3, Jason V Gregory1,3
1Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Macromolecular Rapid Communications
|September 25, 2020
Summary
Researchers developed a new method for creating synthetic protein nanoparticles (SPNPs) using reactive electrojetting. These versatile nanoparticles can be tailored for various applications, including drug delivery and cellular imaging.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Chemical Engineering
Background:
- Protein nanoparticles offer a promising avenue for nanotherapeutics due to their inherent biodegradability and versatile functionalities.
- Existing methods often rely on inert polymers, limiting the scope of functionalization and responsiveness.
Purpose of the Study:
- To develop an adaptable synthesis method for creating synthetic protein nanoparticles (SPNPs) using reactive electrojetting.
- To demonstrate the versatility of SPNPs in terms of protein composition, size control, and functional responsiveness.
- To explore the potential for creating multicompartmental protein nanoparticles.
Main Methods:
- Utilized reactive electrojetting with solutions containing proteins and chemically activated macromers.
- Engineered SPNPs from various proteins including transferrin, insulin, and hemoglobin.
- Developed stimuli-responsive SPNPs by incorporating disulfide-containing macromers.
- Prepared bicompartmental nanoparticles by combining human serum albumin and transferrin.
Main Results:
- Achieved stable and uniform SPNPs with monodisperse sizes around 200 nm under physiological conditions.
- Demonstrated stimuli-responsive behavior in transferrin-based SPNPs, enabling detection of oxidative stress in HeLa cells.
- Successfully fabricated bicompartmental SPNPs with distinct protein hemispheres.
Conclusions:
- Reactive electrojetting provides a versatile platform for synthesizing tunable protein nanoparticles.
- SPNPs can be engineered for specific biological responses and complex architectures.
- This technology opens new possibilities for advanced nanotherapeutics and controlled drug delivery systems.


